Everolimus is the active substance in an immunosuppressive medicine known commercially as Certican.This oral medicine is indicated for the treatment of individuals who have had organ transplants, preventing rejection and eliminating malignant cells.
Everolimo Indications
Rejection of transplanted organs.
Everolimo Side Effects
Decreased leukocytes; increased cholesterol; increased fat; virus infections; anemia;coagulation problems; high pressure; pneumonia; abdominal pain; diarrhea; nausea;vomiting; pimples; urinary infection; swelling; pain; destruction of red blood cells; skin rash;muscle pain; renal necrosis; abnormal liver function.
Everolimo Contraindications
Pregnant or lactating women; Hipersensibility to any of the formula’s components.
Everolimo mode of use
Oral use
Adults
- Kidney or heart transplantation:Start treatment with 0.75 mg twice daily as soon as possible after transplantation.
